Skip to main content
. 2019 Mar 27;63(4):e01814-18. doi: 10.1128/AAC.01814-18

FIG 1.

FIG 1

Percent susceptibility to ceftazidime-avibactam for isolates of Enterobacteriaceae collected in 2012 to 2015, by Latin American country. Ceftazidime-avibactam-susceptible, ≤8 μg/ml; ceftazidime-avibactam-resistant, ≥16 μg/ml, by U.S. FDA criteria. The green font indicates that >90% of isolates were ceftazidime-avibactam-susceptible. ARG, Argentina; BRA, Brazil; CHL, Chile; COL, Colombia; MEX, Mexico; VEN, Venezuela.